Find and Pitch Jounalists, Get Your Story Covered

Tags: nasopharyngeal carcinoma adverse reactions chemotherapy hypothyroidism gemcitabine

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 5 days ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 5 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 7 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - 7 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 7 months ago Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer - 8 months ago Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer - 8 months ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - 10 months ago Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations - 10 months ago FDA OKs First Drug for Nasopharyngeal Carcinoma - 11 months ago Sotorasib's Confirmatory Data in NSCLC Unreliable, Says FDA Panel - 12 months ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - 12 months ago Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial - about 1 year ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 days ago Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC With Adagrasib - 6 months ago FDA Approves Tislelizumab-jsgr for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy - 6 months ago
3	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 6 days ago STAT+: Results on Novartis prostate cancer therapy could expand its use - 11 months ago
4	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 8 days ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - about 1 month ago Study Results Show Low Prevalence of S. Pneumonia Nasopharynx-Oropharynx Colonization - 6 months ago FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC - 7 months ago Pharmacists May See Patients With NSCLC More Often Than Other Care Team Members - 7 months ago FDA Approves Repotrectinib for Treatment of ROS1-Positive NSCLC - 10 months ago
5	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors - 9 days ago
6	MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	'SNL' Alum's Inoperable Cancer; Viral Toddler Checkup; Rocket Fuel Chemical in Food - about 1 month ago
7	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Novel TKI Promising in Early Study of HER2-Mutant NSCLC - 3 months ago
8	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 4 months ago
9	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The latest updates on cancer research from the weekend - 5 months ago
10	Elise Reuter MedTech Dive Reporter @MedTechDive. Covers medical devices. medical technologydigital therapeutics	Exact Sciences, Mayo Clinic share early data on esophageal cancer test - 6 months ago

Journalists covering nasopharyngeal carcinoma